+91 8821 8821 27 support@invc.co.in

Tetraxim Vaccination in Delhi


Book an appointment

Need help?


Tetraxim Vaccination

Availability: Service available Location: Vaccination at centre/ Home Vaccination Category: DTP - IPV Booster

Tetraxim – Sanofi

Indication and Usage –

TETRAXIM vaccine is indicated in the joint prevention of diphtheria, tetanus, pertussis and poliomyelitis:

  • for primary vaccination in infants from the age of 2 months,
  • for booster vaccination, one year after primary vaccination during the second year of life.
  • for booster vaccination between 5 and 13 years of age, according to official recommendations.


Dosage and Administration –

  • Administer via the intramuscular route.
  • Administration should preferably be performed in the antero-lateral side of the thigh (middle third) in infants and in the deltoid area in children.
  • Primary vaccination: 3 injections given at an interval of one month, i.e. according to the official schedule, at the age of 2, 3, 4 months.
  • Booster vaccination: 1 injection one year after primary vaccination, i.e. usually, between 16 and 18 months.
  • Booster vaccination between 5 and 13 years of age: 1 injection.


Contraindications –

  • Hypersensitivity to any of the active substances of TETRAXIM, any of the excipients listed, glutaraldehyde, neomycin, streptomycin, or polymyxin B (used during the manufacturing process and which may be present as traces) and to a pertussis vaccine (acellular or whole cell).
  • Life-threatening reaction after previous administration of the same vaccine or a vaccine containing the same substances.
  • Vaccination must be postponed in case of febrile or acute disease.
  • Evolving encephalopathy.
  • Encephalopathy within 7 days of administration of a previous dose of any vaccine containing pertussis antigens (whole cell or acellular pertussis vaccines).


Adverse reactions –

  • Very common adverse reactions include: Loss of appetite; Nervousness, irritability. Abnormal crying. Somnolence. Headache. Vomiting. Myalgia. Injection-site erythema, Injection-site pain, Injection-site oedema, Fever ≥38°C, Malaise.
  • Common adverse reactions include: Insomnia, sleep disturbances, Diarrhoea, Injection-site induration.
  • Uncommon adverse reactions include: Prolonged Inconsolable crying, Injection-site redness and oedema ≥5 cm, Fever ≥39°C.
  • Rare adverse reactions include: Fever >40°C.


Drug interactions and other interactions –

  • It can be administered simultaneously with the MMR VAXPRO vaccine or with the HB VAXPRO vaccine, but in two separate sites.
  • TETRAXIM vaccine can be associated or combined with the Haemophilus influenzae type b conjugate vaccine (Act-HIB).

Add a Review

Your email address will not be published. Required fields are marked *